International Psychopharmacology Course 2019
International Psychopharmacology Course 2019 is organized by Massachusetts General Hospital (MGH) Psychiatry Academy and will be held from Jul 13 - 14, 2019 at Grand Hotel Des Iles Borromees, Stresa, Verbano-Cusio-Ossola, Italy.
This program is intended for:
• General and Family Practice Physicians
• Psychiatric Nurses
• Physician Assistants
• Nurse Practitioners
• Social Workers
AMA PRA Category 1 CreditsTM
McLean Hospital designates this live activity for a maximum of 11.0 AMA PRA Category 1 creditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Psychologists CE Credit
This offering meeting the criteria for 11.0 Continuing Education (CE) credits per presentation for psychologists.
This offering meets the criteria for 14.75 Continuing Education (CE) credits for psychologists.
Nursing Contact Hours
This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 11.0 contact hours of nursing continuing education credit
11.0 self-claim Credit
The Massachusetts General Hospital Psychiatry Academy is proud to organize a two-day conference offering an in-depth review of the latest knowledge in treatment, epidemiology, and diagnosis across mental health conditions including depression and schizophrenia.
The Massachusetts General Hospital Psychiatry Academy has been hosting the renowned Psychopharmacology Conference in the U.S. for over 40 years. This international course will be interactive and multidisciplinary. It will provide a unique opportunity to understand differing perspectives and approaches from leading mental health experts in the U.S. and Europe, as well as an exceptional forum for networking, exchanging ideas, learning, and sharing experiences with colleagues and faculty.
Conference content includes:
• Treatment Resistant Depression
• Bipolar Depression
• What the future holds for the treatment of Depression and Schizophrenia
• Sessions on Well Being Therapy of Depression, Brain Stimulation of Depression, Psychosis, Antipsychotic therapy and much more
• Curbside consultation with direct interaction with faculty during Q&A sessions and Ask the Expert panels
By the end of this educational activity, participants should be able to:
• Identify rational, evidence-based pharmacologic and non-pharmacologic therapies for patients with unipolar, bipolar, and treatment-resistant depression.
• Assess obstacles to maintenance of long-term recovery and the liability issues associated with psychopharmacology.
• Discuss diagnostic and evidenced-based treatment strategies for pediatric onset mood disorders.
• Compare the newest medications in the pipeline for depression and schizophrenia to those which are currently being used.
• Review the usefulness of well being therapy in depression.
• Discuss the use of brain stimulation in treatment refractory depression.
• Analyze the evolution of antipsychotic therapy with an emphasis on long acting injectable medication.
Course Faculty Include:
Dr. Maurizio Fava, Dr. Cristina Colombo, Dr. Stefano Pallanti, Dr. Siegfried Kasper, Dr. Giovanni Fava, Dr. Joseph Biederman and Dr. Oliver Freudenreich
|Contact No. :||(866) 644-7792
|Registration Type||End Date||Price|
|MDs/Doctoral-Level Professionals Super Early Fee||22 Feb,2019||USD 645.00|
|MDs/Doctoral-Level Professionals Early Registration Fee||03 May,2019||USD 695.00|
|MDs/Doctoral-Level Professionals Regular Registration Fee||12 Jul,2019||USD 795.00|
|Other Professionals or Trainees Super Early Fee||22 Feb,2019||USD 545.00|
|Other Professionals or Trainees Early Registration Fee||03 May,2019||USD 595.00|
|Other Professionals or Trainees Regular Registration Fee||12 Jul,2019||USD 695.00|